Please check here for current or live consultations running in West Berkshire. By getting involved you are helping shape future health and social care services, making your voice count.
If you are running a consultation or survey / project in West Berkshire and would like us to help you spread the word, please get in touch and we can help publish your consultation on our site. Or if we can help you run a consultation then also talk to one of our team.
Click the blue tabs below and follow the link to live consultations
Open Public Consultation on “Strengthened cooperation against vaccine preventable diseases” – ends 15/3/18
Objective of the consultation
Vaccine preventable diseases are major health scourges. Due to their cross-border nature and the challenges to national vaccination programmes, there is need for common EU action and more coordinated approaches to limit the spread of epidemics and cross border diseases. There is clear added-value to strengthen cooperation among all relevant actors at EU level, including health authorities, vacine industry, research and innovation, healthcare sector and others.
In mid-2018, the European Commission will adopt a proposal for a Council Recommendation on Strengthened Cooperation against Vaccine Preventable Diseases. The objective of this public consultation is to collect the views and input of citizens, administrations, associations and other relevant organisations to feed into the process of drafting a proposal for the Council Recommendation.
To take part in this consultation and or view more details, click HERE
Blue Badge scheme: consultation on eligibility – ends 18/3/18
“The Blue Badge scheme plays a vital role in allowing 2.4 million disabled people in England to maintain their independence through special national parking concessions. Blue Badges enable their holders to visit their families and friends and to access healthcare and leisure activities.
The badges are no less important in helping to prevent social exclusion and isolation, and they contribute to the ability of their holders to secure and maintain long term employment. Without the scheme, 75% of badge holders have said that they would go out less often.
The government believes that the Blue Badge scheme should not discriminate in principle between physical and non-physical disabilities.
The current rules embrace all conditions, physical or otherwise, but it has become clear to us that the regulations and guidance are not clearly understood by local authorities. People with hidden disabilities may be finding it difficult to access badges, even though their condition causes them very significant difficulties when undertaking a journey.
The department has accordingly committed to look again at how the scheme works for people with hidden disabilities, to ensure that the rules and guidance are clear and that those with the greatest needs have access to a Blue Badge. This accords with the government’s manifesto commitment to give parity of esteem to mental and physical health conditions.
This consultation document discusses the key issues involved, and presents ideas for improving the rules. The challenge will be to ensure a scheme that is both sustainable and works for all who are eligible for it, whatever their disability.“
To read more about this consultation and to find out how to respond, please click HERE
Public Consultation on the transparency and sustainability of the EU risk assessment in the food chain – ends 20/3/18
Objective of the consultation
The General Food Law Regulation (EU rules on food and feed safety along the production chain) is the cornerstone of the EU regulatory framework covering the entire food chain: ‘from farm to fork’.
The law requires food and feed law to be science-based. This is known as the risk analysis principle, which consists of three separate but interrelated components: risk assessment (scientific advice), risk management (measures taken on the basis of scientific advice, other legitimate factors and where appropriate the precautionary principle) and risk communication (interactive exchange of information on risks throughout the risk analysis process).
For this purpose, the General Food Law Regulation established the European Food Safety Authority (EFSA) as an independent scientific agency to provide the scientific opinions (risk assessment) which form the basis for the measures taken by the EU in the food chain.
Since the adoption of the General Food Law Regulation in 2002, the political, economic and societal context has evolved, affecting consumers’ perception and expectations in relation to the food chain.
Whilst EFSA’s work in the area of risk assessment has not been subject to significant criticism, citizens have put into question the risk assessment based on studies provided by the industry and this in particular where the industry seeks an authorisation, e.g. for pesticides, GMOs etc.
We are keen to hear about your views and experiences on the following:
- the transparency and independence of the EU risk assessment system with respect to the underlying industry studies and information on which EFSA’s risk assessment/scientific advice is based;
- risk communication; and,
- the governance of EFSA, in particular the involvement of the EU Member States (MS) in the EU risk assessment system.
The consultation is also a follow-up to the commitments made by the Commission in reply to the European Citizens’ Initiative on glyphosate.
Your feedback will help us to look into how we can improve the current system and to address citizens’ expectations about independence and transparency of the EU risk assessment system. This exercise will feed into a Commission’s legislative proposal to be presented to the European Parliament and Council by May 2018.
To take part in this consultation click HERE
CQC consults on plans to evolve regulation of independent healthcare services in England – ends 23/3/18
- How CQC plans to introduce quality ratings following its inspections for those independent healthcare services that it was given the power to rate by the Department of Health and Social Care last month.
- Changes to the regulation of independent healthcare services, including the scheduling and intensity of its inspections and how CQC will monitor providers and gather its intelligence on an ongoing basis.
Independent health services are services not funded by the NHS. The CQC have been granted the powers to provide ratings for these services, have your say in how they will do this.
For more information and to find out how to take part in this consultation please click HERE
Specialised Services clinical commissioning policy: Human coagulation factor X for hereditary factor X deficiency (all ages) – ends 25/3/18
NHS England has launched a 30 day public consultation on a clinical commissioning policy proposition for Human coagulation factor X for hereditary factor X deficiency (all ages).
To take part in this consultation, click HERE
Specialised Services clinical commissioning policy: Lomitapide for treating homozygous familial hypercholesterolaemia in adults – ends 25/3/18
NHS England has launched a 30 day public consultation on a clinical commissioning policy proposition for Lomitapide for treating homozygous familial hypercholesterolaemia in adults.
To take part in this consultation please click HERE
Specialised Services clinical commissioning policy: Left Atrial Appendage Occlusion for patients with atrial fibrillation and relative or absolute contraindications to anticoagulation (Adults) – ends 1/4/18
NHS England has launched a 30 day public consultation on a clinical commissioning policy proposition for Left Atrial Appendage Occlusion for patients with atrial fibrillation and relative or absolute contraindications to anticoagulation (Adults).
Visit: http://bit.ly/2InHr4o to take part in this consultation
Specialised Services specification consultation: DNA Nucleotide Excision Repair Disorders Service (all ages) – ends 1/4/18
NHS England has launched a 30 day public consultation on a service specification proposition for DNA Nucleotide Excision Repair Disorders Service (all ages).
To participate in this consultation click – HERE
Specialised Services clinical commissioning policy: Bortezomib for Relapsed/ Refractory Waldenstrom’s Macroglobulinaemia – ends 24/4/18
NHS England has launched a 60 day public consultation on a clinical commissioning policy proposition for Bortezomib for Relapsed/ Refractory Waldenstrom’s Macroglobulinaemia.
To take part in this consultation and/or see more details, visit THIS website
Specialised Services: Recommendations for an NHS England algorithm to use disease-modifying drugs to treat multiple sclerosis – ends 5/5/18
NHS England has launched a 60 day public consultation on recommendations for an algorithm to use disease-modifying drugs to treat multiple sclerosis.
Click HERE to take part in this consultation.